Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: Meconi F,Provenzano I, Nasso D, Mariotti B, Pupo L, Secchi R, Cerretti R, Lucia A, Arcese W, Cantonetti M
Date: 2020
Scope of interest: Haematology
Authors: Ottini L, et.al., D'Amico C, et al.
Date: 2013
Scope of interest: Molecular Oncology
Authors: Abbatecola AM, Paolisso G
Date: 2007
Scope of interest: endocrinology, aging
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide